Healthcare Services

Eye Infections Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Eye Infections Market Expected To Change Between 2026 And 2030?

The eye infections market has experienced robust expansion in recent years. Its valuation is expected to climb from $7.93 billion in 2025 to $8.36 billion in 2026, registering a compound annual growth rate (CAGR) of 5.4%. During the historic period, this growth was primarily driven by the high incidence of conjunctivitis and keratitis, the increasing usage of contact lenses, a rise in urban pollution, improved healthcare access, and the ongoing expansion of ophthalmology clinics.

The eye infections market is projected to experience robust expansion in the upcoming years, with its valuation expected to climb to $10.24 billion by 2030, achieving a compound annual growth rate (CAGR) of 5.2%. This growth throughout the forecast period can be attributed to several factors, including the introduction of novel antimicrobial eye drugs, an increasing aging population, a rise in cases of digital eye strain, enhanced access to ophthalmic care, and the burgeoning presence of online pharmacies. Significant trends anticipated during this period encompass a rising prevalence of bacterial and viral eye infections, a greater reliance on prescription ophthalmic drugs, an escalating awareness of the importance of early diagnosis and treatment, the expansion of online and retail pharmacy channels, and the development of broad-spectrum ophthalmic therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21186&type=smp

Which Major Factors Are Driving The Expansion Of The Eye Infections Market?

The rising occurrence and spread of ocular conditions are anticipated to fuel the expansion of the eye infections market. Ocular conditions encompass various ailments impacting the eyes, including illnesses like glaucoma, cataracts, macular degeneration, and refractive issues such as myopia and hyperopia. The growing patient count with eye-related disorders stems from factors such as an aging global population, shifts in lifestyle, environmental influences, and insufficient diagnostic tools resulting in delayed problem identification. Eye infections have the potential to initiate or exacerbate eye-related disorders by inducing inflammation, causing tissue damage, and weakening the eye’s inherent protective mechanisms, eventually leading to serious outcomes such as vision impairment or persistent ailments. For instance, in October 2024, as reported by the World Health Organization, a Switzerland-based health authority, during 2023, 130,746 individuals received surgical intervention for advanced trachoma, and 32.9 million were administered antibiotics, achieving a global coverage of 29%. Consequently, the growing incidence and prevalence of eye-related disorders are set to propel the eye infections market in the future.

How Is The Eye Infections Market Structured Across Different Segments?

The eye infections market covered in this report is segmented –

1) By Indications: Conjunctivitis, Keratitis, Endophthalmitis, Blepharitis, Stye, Uveitis, Cellulitis, Ocular Herpes

2) By Drug Type: Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Conjunctivitis: Bacterial Conjunctivitis, Viral Conjunctivitis, Allergic Conjunctivitis

2) By Keratitis: Bacterial Keratitis, Viral Keratitis, Fungal Keratitis, Acanthamoeba Keratitis

3) By Endophthalmitis: Post-surgical Endophthalmitis, Post-traumatic Endophthalmitis, Endogenous Endophthalmitis

4) By Blepharitis: Anterior Blepharitis, Posterior Blepharitis

5) By Stye: Internal Stye, External Stye

6) By Uveitis: Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Panuveitis

7) By Cellulitis: Periorbital Cellulitis, Orbital Cellulitis

8) By Ocular Herpes: Herpes Simplex Keratitis, Herpes Simplex Conjunctivitis

Which Trends Are Shaping The Future Of The Eye Infections Market?

Major companies operating within the eye infections market are prioritizing the development of novel therapies, such as photodynamic therapy, to enhance treatment effectiveness and mitigate side effects. Photodynamic therapy is a medical procedure that involves the application of a light-sensitive drug, activated by specific light wavelengths, to identify and eradicate abnormal or infected cells. For example, in December 2024, VisiRose Inc., a US-based clinical-stage biotechnology company, joined forces with Provectus Biopharmaceuticals Inc., a US-based pharmaceutical company, and Bascom Palmer Eye Institute, a US-based health center, to introduce Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT). This is a groundbreaking, non-invasive investigational treatment intended for infectious keratitis and other severe eye infections. The RB PDAT offers a promising resolution to the escalating global problem of antimicrobial resistance (AMR) by providing a broad-spectrum ocular treatment. This therapy is engineered to be safe, efficacious, and economical, addressing the critical demand for innovative treatments in this domain.

Which Major Players Dominate The Eye Infections Market?

Major companies operating in the eye infections market are Pfizer Inc, F. Hoffmann-La Roche AG, Merck And Co Inc, AbbVie Inc., Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals Inc, Alcon Laboratories Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Santen Pharmaceuticals Co Ltd, Rohto Pharmaceutical Co Ltd, Alembic Pharmaceuticals Limited, Novaliq GmbH, Eyevance Pharmaceuticals LLC, Ocular Therapeutix, I-Med Pharma Inc., EyeGate Pharmaceuticals Inc

Read the full eye infections market report here:

https://www.thebusinessresearchcompany.com/report/eye-infections-global-market-report

Which Region Currently Holds The Largest Share Of The Eye Infections Market?

North America was the largest region in the eye infections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye infections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Eye Infections Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21186&type=smp

Browse Through More Reports Similar to the Global Eye Infections Market 2026, By The Business Research Company

Ocular Inflammation Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/ocular-inflammation-treatment-global-market-report

Veterinary Eye Care Global Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-eye-care-global-market-report

Anemia And Other Blood Disorder Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795